IMUNON restructures operations to focus on phase 3 ovarian cancer trial
Tweet Send to a Friend
IMUNON Inc. (NASDAQ: IMNN) announced a strategic reorganization that will reduce headcount and operating expenses to focus resources on its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


